Dmytro Havrylyuk

ORCID: 0000-0001-7766-9923
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Synthesis and biological activity
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Synthesis and Characterization of Heterocyclic Compounds
  • Click Chemistry and Applications
  • Metal complexes synthesis and properties
  • Synthesis of heterocyclic compounds
  • Synthesis and Biological Evaluation
  • Photodynamic Therapy Research Studies
  • Nanoplatforms for cancer theranostics
  • Crystallography and molecular interactions
  • Synthesis and Reactivity of Sulfur-Containing Compounds
  • Ferrocene Chemistry and Applications
  • Multicomponent Synthesis of Heterocycles
  • Computational Drug Discovery Methods
  • Histone Deacetylase Inhibitors Research
  • Photochromic and Fluorescence Chemistry
  • Pharmacogenetics and Drug Metabolism
  • Synthesis and Reactions of Organic Compounds
  • Cancer, Hypoxia, and Metabolism
  • Drug Transport and Resistance Mechanisms
  • Inflammatory mediators and NSAID effects
  • Organometallic Complex Synthesis and Catalysis
  • Fluorine in Organic Chemistry
  • Research on Leishmaniasis Studies

North Carolina State University
2024-2025

University of Kentucky
2016-2023

Dragomanov Ukrainian State University
2020

Danylo Halytsky Lviv National Medical University
2008-2017

The synthesis and antitumor activity screening of novel 3-[2-(3,5-diaryl-4,5-dihydropyrazol-1-yl)-4-oxo-4,5-dihydro-1,3-thiazol-5-ylidene]-2,3-dihydro-1H-indol-2-ones 1-23 3-(3,5-diarylpyrazol-1-yl)-2,3-dihydro-1H-indol-2-ones 24-39 are performed. In vitro anticancer the synthesized compounds was tested by National Cancer Institute. Most them displayed on leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate, breast cancers cell lines. structure-activity relationship is discussed....

10.1021/jm300789g article EN Journal of Medicinal Chemistry 2012-09-20

10.1016/j.jmgm.2014.10.006 article EN Journal of Molecular Graphics and Modelling 2014-11-01

Ru(II) complex photocages are used in a variety of biological applications, but the thermal stability, photosubstitution quantum yield, and compatibility most commonly systems remain unoptimized. Here, multiple compounds photocaging applications were analyzed found to have several unsatisfactory characteristics. To address these deficiencies, three new scaffolds designed improve key properties through modulation combination electronic, steric, physiochemical features. One systems, containing...

10.1021/acs.inorgchem.9b02065 article EN Inorganic Chemistry 2020-01-03

Abstract The cytochrome P450 family of enzymes (CYPs) are important targets for medicinal chemistry. Recently, CYP1B1 has emerged as a key player in chemotherapy resistance the treatment cancer. This enzyme is overexpressed variety tumors, and correlated with poor outcomes; thus, it desirable to develop inhibitors restore efficacy. However, possible off-target effects, such inhibition liver CYPs responsible first pass metabolism, make selective high priority avoid drug-drug interactions...

10.1038/s41467-022-31269-5 article EN cc-by Nature Communications 2022-06-25

Hyperpolarization derived from signal amplification by reversible exchange (SABRE) is valued for its relative simplicity among hyperpolarization approaches. Here, we demonstrate that photoejection of the ligands pyridazine and pyrazine prodrug Ru(II) polypyridyl complexes offers a new modality activating SABRE hyperpolarization, achieving enhancements over 3200-fold.

10.1039/d4cc06807f article EN cc-by-nc Chemical Communications 2025-01-01

The synthesis and antitumor activity screening of novel isatin based conjugates with thiazolidine pyrazoline moieties were performed. Reaction 3,5-diaryl-4,5-dihydropyrazoles chloroacetyl chloride yielded starting 2-chloro-1-(3,5-diaryl-4,5-dihydropyrazol-1-yl)-ethanones which utilized in alkylation 5-bromoisatin. Thus, corresponding 1-[2-(3,5-diaryl-4,5-dihydropyrazol-1-yl)-2-oxoethyl]-1H-indole-2,3-diones (1a-1d) have been obtained. compounds 1a-1d used Knoevenagel condensation...

10.1002/ardp.201100055 article EN Archiv der Pharmazie 2011-06-16

2‐(4,5‐Dihydropyrazol‐1‐yl)‐thiazol‐4‐ones ( 2–5 ) have been synthesized starting from 3‐phenyl‐5‐aryl‐1‐thiocarbamoyl‐2‐pyrazolines via [2+3]‐cyclization with 2‐bromopropionic acid, maleic anhydride, N ‐arylmaleimides, and aroylacrylic acids. The in vitro anticancer activity of 2a , 3a 4a 5b 5c were tested by the National Cancer Institute. Compounds demonstrated selective inhibition leukemia cell lines growth at a single concentration (10 −5 M). screening antiviral for broad panel viruses...

10.1002/jhet.1056 article EN Journal of Heterocyclic Chemistry 2013-02-01

Ruthenium complexes capable of light‐triggered cytotoxicity are appealing potential prodrugs for photodynamic therapy (PDT) and photoactivated chemotherapy (PACT). Two groups (polypyridyl)Ru II with 2‐(2‐pyridyl)benzazole ligands were synthesized investigated their photochemical properties anticancer activity to compare strained unstrained systems that likely have different biological mechanisms action. The structure–activity relationship was focused on the benzazole‐core bioisosterism...

10.1002/ejic.201601450 article EN European Journal of Inorganic Chemistry 2017-01-31

A series of strained Ru(II) complexes were studied for potential anticancer activity in hypoxic tissues. The constructed with methylated ligands that photolabile and an imidizo[4,5-f][1,10]phenanthroline ligand contained appended aromatic group to potentially allow contributions ligand-centered excited states. systematic variation the size energy was performed using systems containing 1-4 fused rings, photochemical photobiological behaviors all assessed. structure nature had a subtle impact...

10.1111/php.13174 article EN Photochemistry and Photobiology 2019-11-06

A series of new 2-{4-oxo-2-[(4-oxothiazolidin-2-ylidene)-hydrazono]-thiazolidin-5-yl}-N-arylacetamides ( 4a–e ), 5-(2-oxo-2-aryl-ethyl)-2-[(4-oxothiazolidin-2-ylidene)-hydrazono]-thiazolidine-4-ones 5a–d 2-(4-oxo-2-[(2-oxothiazolidin-4-ylidene)-hydrazono]-thiazolidin-5-yl)-N-arylacetamides 7a–e and 5-(2-oxo-2-aryl-ethyl)-2-[(2-oxothiazolidin-4-ylidene)-hydrazono]-thiazolidine-4-ones 8a–d ) have been synthesized starting from 2-thioxothiazolidin-4-one 4-thioxothiazolidin-2-one through a...

10.1080/10426500802247563 article EN Phosphorus, sulfur, and silicon and the related elements 2009-02-19

Coordination complexes can be used to photocage biologically active ligands, providing control over the location, time, and dose of a delivered drug.

10.1039/c8cc05809a article EN Chemical Communications 2018-01-01

Abstract In an earlier study of π‐expansive ruthenium complexes for photodynamic and photochemo‐therapies, it was shown that a pair structural isomers differing only in the connection point naphthalene residue exhibited vastly different biological activity. These are further explored this paper through activity their functionalized derivatives. normoxia, inactive 2‐NIP isomer ( 5 ) can be made as photocytotoxic active 1‐NIP 1 by functionalizing with methyl or methoxy groups, while variants...

10.1111/php.13395 article EN Photochemistry and Photobiology 2021-02-10

While cytochrome P450 (CYP; P450) enzymes are commonly associated with the metabolism of organic xenobiotics and drugs or biosynthesis signaling molecules, they also impacted by a variety inorganic species. Metallic nanoparticles, clusters, ions, complexes can alter CYP expression, modify enzyme interactions reductase partners, serve as direct inhibitors. This overlooked topic is reviewed here, an emphasis on understanding structural physiochemical basis for these interactions. Intriguingly,...

10.3390/biom14040441 article EN cc-by Biomolecules 2024-04-04

The discovery of new light-triggered prodrugs based on ruthenium (II) complexes is a promising approach for photoactivated chemotherapy (PACT). light-mediated activation "strained" Ru(II) polypyridyl resulted in ligand release and produced ligand-deficient metal center capable forming covalent adducts with biomolecules such as DNA. Based the strategy exploiting structural distortion to activate photochemistry, biologically active small molecules were coordinated scaffold create dual-action...

10.1021/acsomega.0c02079 article EN publisher-specific-oa ACS Omega 2020-07-23

Ruthenium complexes are often investigated as potential replacements for platinum-based chemotherapeutics in hopes of identifying systems with improved tolerability vivo and reduced susceptibility to cellular resistance mechanisms. Inspired by phenanthriplatin, a non-traditional platinum agent that contains only one labile ligand, monofunctional ruthenium polypyridyl agents have been developed, but until now, few demonstrated promising anticancer activity. Here we introduce potent new...

10.1039/d2cb00247g article EN cc-by-nc RSC Chemical Biology 2023-01-01

The features of the chemistry 4-thiazolidinone and isatin as privileged scaffolds were described in a number reviews which main approaches to synthesis mentioned heterocycles their pharmacological action analyzed. However, 4-thiazolidinone-indoline conjugates well based heterocyclic hybrids biologically active compounds is poorly discussed context pharmacophore hybrid approach. Therefore, purpose this review summarize data about biological activity systems with thiazolidinone 2-oxoindoline...

10.2174/1570193x11666141028231910 article EN Mini-Reviews in Organic Chemistry 2014-10-29
Coming Soon ...